MLN4924, a novel inhibitor targeting the ubiquitin ligase SCF E3, sensitizes CRC cells to irradiation by inducing cell cycle arrest and increasing apoptosis and DNA damage, which can be used in combination therapy with chemotherapeutic agents on the basis of broken DNA levels in the future (Wan et al. 2016). This evidence concerns the gene KITLG and colorectal carcinoma.